Over the last six years, three GLP-1 drugs have been approved for children aged 10 and older with Type 2 diabetes. | Over the ...
Being diagnosed with type 2 diabetes at 35 can come as a shock, and it’s only natural to have doubts about medicines. So, ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options ...
Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss? There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether ...
MELBOURNE, Australia — The use of IDegLira, a fixed-ratio combination of the glucagonlike peptide (GLP)-1 receptor agonist liraglutide (Victoza, Novo Nordisk) and insulin degludec (Tresiba, Novo ...
Although T2D hospitalization rates were nearly identical across treatment groups, risk for subsequent hospitalization was lower with liraglutide vs glimepiride. Among people with type 2 diabetes (T2D) ...
(HealthDay News) — In insulin-naive patients with type 2 diabetes, 12 weeks of treatment with liraglutide or sitagliptin has no effect on renal hemodynamics, according to a study published online in ...
COPENHAGEN, Sept 13 (Reuters) - Danish drugmaker Novo Nordisk said new data showed people with type 2 diabetes experienced improvements in controlling blood sugar levels when using its diabetes drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback